Robert Burns, an analyst from H.C. Wainwright, reiterated the Buy rating on Black Diamond Therapeutics (BDTX – Research Report). The ...

Black Diamond Therapeutics, Inc. (BDTX) announced positive initial Phase 2 results for BDTX-1535 in patients with relapsed or ...

Black Diamond Therapeutics (NASDAQ:BDTX) reported encouraging Phase 2 data for its drug candidate BDTX-1535 in the treatment ...

Hit by fall in demand, revenue of the natural diamond polishing industry may drop to decadal low after expected fall of 27 per cent to $12 billion this fiscal. The muted demand in the US and China ...

The report stated that tepid demand amid decreasing prices has seen diamond polishers limiting the purchase of roughs and have curbed manufacturing. In turn, miners have cut production and eased ...

Set to take place in November, the Royal and Noble Jewels auction will be led by a dazzling, 18th-century diamond necklace with an equally dazzling pre-sale estimate of between $1.8 million and $2 ...

The Texas Rangers are prepared to pursue creating a regional sports network of their own when the season and current contract with the parent company of Bally Sports Southwest end Sunday, a person ...

Black Diamond Therapeutics and Ideaya Biosciences are mulling over registrational trials for their lead assets after ...

The detailed information on the affairs of the Company has been covered under the Management Discussion & Analysis, forming part of this Annual Report. In terms of the NCLT order dated 20 th June ...

Raymond James has recently initiated Black Diamond Therapeutics Inc (BDTX) stock to Outper form rating, as announced on July 31, 2024, according to Finviz. Earlier, on July 14, 2023, Piper Sandler had ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 23.80% ...